This white paper provides insight into considerations when outsourcing Qualified Person for Pharmacovigilance (QPPV) services. It also touches upon potential challenges with oversight of the Marketing Authorization Holder (MAH) pharmacovigilance system.
Explore related content and topics
White Paper
Sponsor and CRO Pharmacovigilance and Safety Alliances
Outsourcing pharmacovigilance is a standard business practice in a rapidly expanding market segment. In this new whitepaper, PRA’s Sabine Richter…
View Resource
White Paper
Literature Surveillance
Literature surveillance is an important tool in the suite of monitoring activities to ensure the safety of medicinal products. The success of…
View Resource
Newsletter
PV Nugget #7 Pharmacogenomics
Pharmacogenomics (PGx) focuses on how genes and biomarkers can affect how an individual respond to drugs. The goal of PGx is to develop effective,…
View Resource
View all related content and resources for Pharmacovigilance
Explore Insights